A previous study revealed high levels of PSMA7 in salivary exosomes in patients with inflammatory bowel disease, suggesting that PSMA7 is a promising biomarker alternative to colonoscopy 46. This evidence concerns the gene PSMA7 and inflammatory bowel disease.